BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Hamza M, Halayem S, Bourgou S, Daoud M, Charfi F, Belhadj A. Epigenetics and ADHD: Toward an Integrative Approach of the Disorder Pathogenesis. J Atten Disord 2019;23:655-64. [PMID: 28665177 DOI: 10.1177/1087054717696769] [Cited by in Crossref: 30] [Cited by in F6Publishing: 33] [Article Influence: 7.5] [Reference Citation Analysis]
Number Citing Articles
1 Choi YJ, Cho J, Hong YC, Lee DW, Moon S, Park SJ, Lee KS, Shin CH, Lee YA, Kim BN, Kaminsky Z, Kim JI, Lim YH. DNA methylation is associated with prenatal exposure to sulfur dioxide and childhood attention-deficit hyperactivity disorder symptoms. Sci Rep 2023;13:3501. [PMID: 36859453 DOI: 10.1038/s41598-023-29843-y] [Reference Citation Analysis]
2 Sato JR, Biazoli CE, Bueno APA, Caye A, Pan PM, Santoro M, Honorato-Mauer J, Salum GA, Hoexter MQ, Bressan RA, Jackowski AP, Miguel EC, Belangero S, Rohde LA. Polygenic risk score for attention-deficit/hyperactivity disorder and brain functional networks segregation in a community-based sample. Genes Brain Behav 2023;:e12838. [PMID: 36811275 DOI: 10.1111/gbb.12838] [Reference Citation Analysis]
3 Meijer M, Franke B, Sandi C, Klein M. Epigenome-wide DNA methylation in externalizing behaviours: A review and combined analysis. Neurosci Biobehav Rev 2023;145:104997. [PMID: 36566803 DOI: 10.1016/j.neubiorev.2022.104997] [Reference Citation Analysis]
4 White M, Lafaille-magnan M, Roche C, Jolicoeur-martineau A, Wazana A, Connor KL. Developmental Origins, Differential Susceptibility, and Resilience in Neurodevelopmental Disorders. Neurodevelopmental Pediatrics 2023. [DOI: 10.1007/978-3-031-20792-1_45] [Reference Citation Analysis]
5 Mondal P, Sarkar S, Das A. Epigenetic regulations in neurological disorders. Epigenetics in Organ Specific Disorders 2023. [DOI: 10.1016/b978-0-12-823931-5.00010-4] [Reference Citation Analysis]
6 Rasmi Y, Shokati A, Hassan A, Aziz SG, Bastani S, Jalali L, Moradi F, Alipour S. The role of DNA methylation in progression of neurological disorders and neurodegenerative diseases as well as the prospect of using DNA methylation inhibitors as therapeutic agents for such disorders. IBRO Neurosci Rep 2023;14:28-37. [PMID: 36590248 DOI: 10.1016/j.ibneur.2022.12.002] [Reference Citation Analysis]
7 Kelvington BA, Nickl-Jockschat T, Abel T. Neurobiological insights into twice-exceptionality: Circuits, cells, and molecules. Neurobiol Learn Mem 2022;195:107684. [PMID: 36174887 DOI: 10.1016/j.nlm.2022.107684] [Reference Citation Analysis]
8 Liu X, Zhang G. Functional urination or defecation disorders may be warning signs of attention-deficit/hyperactivity disorder among children in rural China. J Affect Disord 2022;316:63-70. [PMID: 35981625 DOI: 10.1016/j.jad.2022.08.029] [Reference Citation Analysis]
9 Zetterström TSC, Quansah E, Grootveld M. Effects of Methylphenidate on the Dopamine Transporter and Beyond. Curr Top Behav Neurosci 2022;57:127-57. [PMID: 35507284 DOI: 10.1007/7854_2022_333] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
10 Peedicayil J. The Role of Epigenetics in the Pathogenesis and Potential Treatment of Attention Deficit Hyperactivity Disorder. Curr Neuropharmacol 2022;20:1642-50. [PMID: 34544344 DOI: 10.2174/1570159X19666210920091036] [Reference Citation Analysis]
11 Hubers N, Hagenbeek FA, Pool R, Déjean S, Harms AC, Roetman PJ, van Beijsterveldt CEM, Fanos V, Ehli EA, Vermeiren RRJM, Bartels M, Hottenga JJ, Hankemeier T, van Dongen J, Boomsma DI. Integrative multi-omics analysis of genomic, epigenomic, and metabolomics data leads to new insights for Attention-Deficit/Hyperactivity Disorder.. [DOI: 10.1101/2022.07.21.22277887] [Reference Citation Analysis]
12 Robinson LR, Bitsko RH, O'Masta B, Holbrook JR, Ko J, Barry CM, Maher B, Cerles A, Saadeh K, MacMillan L, Mahmooth Z, Bloomfield J, Rush M, Kaminski JW. A Systematic Review and Meta-analysis of Parental Depression, Antidepressant Usage, Antisocial Personality Disorder, and Stress and Anxiety as Risk Factors for Attention-Deficit/Hyperactivity Disorder (ADHD) in Children. Prev Sci 2022. [PMID: 35641729 DOI: 10.1007/s11121-022-01383-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
13 Hohmann S, Häge A, Millenet S, Banaschewski T. [The Genetic Basis of ADHD - An Update]. Z Kinder Jugendpsychiatr Psychother 2021;50:203-17. [PMID: 35514173 DOI: 10.1024/1422-4917/a000868] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Spencer AE, Oblath R, Sheldrick RC, Ng LC, Silverstein M, Garg A. Social Determinants of Health and ADHD Symptoms in Preschool-Age Children. J Atten Disord 2022;26:447-55. [PMID: 33641514 DOI: 10.1177/1087054721996458] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
15 Barreto-zarza F, Sánchez de Miguel M, Arranz-freijo EB, Acha J, González L, Rebagliato M, Ibarluzea J. Family Context and ADHD Symptoms in Middle Childhood: an Explanatory Model. J Child Fam Stud. [DOI: 10.1007/s10826-021-02206-9] [Reference Citation Analysis]
16 Mastnak W. Chinese Music Therapy and Clinical Music Education in Attention Deficit Hyperactivity Disorder. MODERN APPLIED MEDICAL RESEARCH 2022. [DOI: 10.36099/mamr.210122] [Reference Citation Analysis]
17 Edinoff AN, Apgar TL, Rogers JJ, Harper JD, Cornett EM, Kaye AM, Kaye AD. Attention Deficit Hyperactivity Disorder and Bipolar Disorder: Diagnosis, Treatments, and Clinical Considerations: A Narrative Review. Psychiatry International 2022;3:17-28. [DOI: 10.3390/psychiatryint3010002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
18 Li SC, Kuo HC, Huang LH, Chou WJ, Lee SY, Chan WC, Wang LJ. DNA Methylation in LIME1 and SPTBN2 Genes Is Associated with Attention Deficit in Children. Children (Basel) 2021;8:92. [PMID: 33572947 DOI: 10.3390/children8020092] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
19 Sigurdardottir HL, Kranz GS, Rami-Mark C, James GM, Vanicek T, Gryglewski G, Berroterán-Infante N, Kautzky A, Hienert M, Traub-Weidinger T, Mitterhauser M, Wadsak W, Hartmann AM, Hacker M, Rujescu D, Kasper S, Lanzenberger R. Association of norepinephrine transporter methylation with in vivo NET expression and hyperactivity-impulsivity symptoms in ADHD measured with PET. Mol Psychiatry 2021;26:1009-18. [PMID: 31383926 DOI: 10.1038/s41380-019-0461-x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 8.0] [Reference Citation Analysis]
20 Weiß AL, Meijer M, Budeus B, Pauper M, Hakobjan M, Groothuismink J, Shi Y, Neveling K, Buitelaar JK, Hoogman M, Franke B, Klein M. DNA methylation associated with persistent ADHD suggests TARBP1 as novel candidate. Neuropharmacology 2021;184:108370. [PMID: 33137342 DOI: 10.1016/j.neuropharm.2020.108370] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
21 Hemmingsen CH, Kjaer SK, Jezek AH, Verhulst FC, Pagsberg AK, Kamper-Jørgensen M, Mørch LS, Hargreave M. Maternal use of hormonal contraception and risk of childhood ADHD: a nationwide population-based cohort study. Eur J Epidemiol 2020;35:795-805. [PMID: 32968938 DOI: 10.1007/s10654-020-00673-w] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
22 Meijer M, Klein M, Hannon E, van der Meer D, Hartman C, Oosterlaan J, Heslenfeld D, Hoekstra PJ, Buitelaar J, Mill J, Franke B. Genome-Wide DNA Methylation Patterns in Persistent Attention-Deficit/Hyperactivity Disorder and in Association With Impulsive and Callous Traits. Front Genet 2020;11:16. [PMID: 32082368 DOI: 10.3389/fgene.2020.00016] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 3.3] [Reference Citation Analysis]
23 Mooney MA, Ryabinin P, Wilmot B, Bhatt P, Mill J, Nigg JT. Large epigenome-wide association study of childhood ADHD identifies peripheral DNA methylation associated with disease and polygenic risk burden. Transl Psychiatry 2020;10:8. [PMID: 32066674 DOI: 10.1038/s41398-020-0710-4] [Cited by in Crossref: 39] [Cited by in F6Publishing: 39] [Article Influence: 13.0] [Reference Citation Analysis]
24 Zian Z, Bouhoudan A. Salivary Biomarkers in Neurologic Diseases. Saliva in Health and Disease 2020. [DOI: 10.1007/978-3-030-37681-9_7] [Reference Citation Analysis]
25 Nuzziello N, Craig F, Simone M, Consiglio A, Licciulli F, Margari L, Grillo G, Liuni S, Liguori M. Integrated Analysis of microRNA and mRNA Expression Profiles: An Attempt to Disentangle the Complex Interaction Network in Attention Deficit Hyperactivity Disorder. Brain Sci 2019;9:E288. [PMID: 31652596 DOI: 10.3390/brainsci9100288] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 3.3] [Reference Citation Analysis]
26 Schmitz J, Kumsta R, Moser D, Güntürkün O, Ocklenburg S. DNA methylation of dopamine-related gene promoters is associated with line bisection deviation in healthy adults. Sci Rep 2019;9:5902. [PMID: 30976054 DOI: 10.1038/s41598-019-42553-8] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
27 Grant DE. Scientific Nooses: Epigenetics and Contemporary Injuries. Black Men, Intergenerational Colonialism, and Behavioral Health 2019. [DOI: 10.1007/978-3-030-21114-1_4] [Reference Citation Analysis]
28 Mahadevan J, Kandasamy A, Benegal V. Situating adult attention-deficit/hyperactivity disorder in the externalizing spectrum: Etiological, diagnostic, and treatment considerations. Indian J Psychiatry 2019;61:3-12. [PMID: 30745648 DOI: 10.4103/psychiatry.IndianJPsychiatry_549_18] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
29 Labra-spröhnle F, Smith G, Ahammer H, Postlethwaite C, Liu I, Teesdale-spittle P, Frean M. Predictive Modelling of The Dynamic Patterns of Thinking in Attention-Deficit/Hyperactivity Disorder: Diagnostic Accuracy of Spatiotemporal Fractal Measures.. [DOI: 10.1101/420513] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
30 Nigg JT. Toward an Emerging Paradigm for Understanding Attention-Deficit/Hyperactivity Disorder and Other Neurodevelopmental, Mental, and Behavioral Disorders: Environmental Risks and Epigenetic Associations. JAMA Pediatr 2018;172:619-21. [PMID: 29799950 DOI: 10.1001/jamapediatrics.2018.0920] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 2.6] [Reference Citation Analysis]
31 Farah R, Haraty H, Salame Z, Fares Y, Ojcius DM, Said Sadier N. Salivary biomarkers for the diagnosis and monitoring of neurological diseases. Biomed J 2018;41:63-87. [PMID: 29866603 DOI: 10.1016/j.bj.2018.03.004] [Cited by in Crossref: 79] [Cited by in F6Publishing: 80] [Article Influence: 15.8] [Reference Citation Analysis]
32 Mcpherson P, Yetman M, Burns CO, Wynn B. The Assessment of ADHD in Persons with Developmental Disabilities. Handbook of Childhood Psychopathology and Developmental Disabilities Assessment 2018. [DOI: 10.1007/978-3-319-93542-3_8] [Reference Citation Analysis]